Inogen, Inc. (INGN)
6.69
-0.03
(-0.45%)
USD |
NASDAQ |
Dec 31, 10:17
Inogen EPS Diluted (Quarterly): -0.1955 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Artivion, Inc. | 0.1332 |
| Intuitive Surgical, Inc. | 1.947 |
| West Pharmaceutical Services, Inc. | 1.928 |
| Glaukos Corp. | -0.2828 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.294M |
| Revenue (Quarterly) | 92.39M |
| Total Expenses (Quarterly) | 97.68M |
| Enterprise Value | 76.15M |
| Gross Profit Margin (Quarterly) | 54.36% |
| Profit Margin (Quarterly) | -5.73% |
| Earnings Yield | -15.01% |
| Normalized Earnings Yield | -14.49 |